Center for Disease Analysis Foundation Announces Receipt of an $8 Million Grant from Gilead Sciences to Relink Hepatitis B and C Patients to Care in the United States

LAFAYETTE, Colo., July 20, 2023 (GLOBE NEWSWIRE) -- The Center for Disease Analysis Foundation (CDA Foundation) announced today that it received an $8 million grant from Gilead Sciences (Nasdaq: GILD) as part of Gilead’s Relink grant program. CDA Foundation will disperse the grant to qualifying tax-exempt organizations to contact diagnosed but untreated patients with hepatitis C virus (HCV) or hepatitis B virus (HBV) infection to bring them back into care.

Despite the availability of existing treatment and vaccination options; in the United States an estimated 2.4 million people are living with HCV, and 850,000 are estimated to be living with HBV, according to the U.S. Department of Health and Human Services. Both viruses are responsible for increasing rates of cirrhosis, liver cancer, liver failure and premature deaths. According to CDA Foundation’s research, the risk of developing cancer for someone infected with HCV or HBV infection is the same as someone who smokes one pack of cigarettes per day. HCV and HBV are associated not only with liver cancer but also increased risk of lymphoma, diabetes, insulin resistance, renal disease, fatigue, cognitive impairment, depression, impaired quality of life, arthritis, fibromyalgia and cardiovascular disorders.

Recognizing the growing continued risk of viral hepatitis, the World Health Organization set a global target to eliminate viral hepatitis as a major public health threat by 2030. Despite the availability of oral drugs with high cure rates for HCV and effective therapies for HBV, this goal has been impeded because many patients diagnosed with viral hepatitis are unaware of their infection, do not seek follow-up care, or delay treatment. According to a recent study by U.S. CDC, less than 30% of all Medicaid, Medicare, and private insurance recipients initiate treatment within one year of being diagnosed in the U.S. The Relink grant program aims to identify and work to bridge the gaps that remain in linking patients back to necessary care and treatment.

Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19 and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.

“Hepatitis B and C viruses are highly cancer causing. The Gilead Relink grant is an important example of how public and private partnership can shape viral hepatitis elimination programs that will help the United States achieve WHO targets by 2030,” said Homie Razavi, Founder and Managing Director, CDA Foundation. “In order to improve viral hepatitis patient outcomes in the United States, we must ensure that individuals not only have access to but are also guided toward affordable and effective prevention, care and treatment services.”

“Gilead has been committed to improving the lives of people living with liver disease for more than two decades, and we are thrilled to expand our support to healthcare organizations through the new Gilead Relink grant program,” said Macky Natha, Vice President, Medical Affairs, Gilead Sciences. “As we work toward eliminating viral hepatitis as a public health threat by 2030, we must address barriers to treatment by relinking the people who have been lost in the process, and that’s what the CDA Foundation and other impactful organizations will help accomplish through this program.”

For more information, please visit https://cdafound.org/relink or contact CDA Foundation at relink@cdafound.org.

About Center for Disease Analysis Foundations

CDA Foundation is a non-profit organization that seeks to help eliminate HBV and HCV globally by 2030 by providing countries across the world with verified epidemiological data, disease burden and economic impact modeling, smart intervention strategies, access to affordable diagnostics and treatments, innovative financing, and knowledge-sharing partnerships to eliminate these deadly infections. It works with more than 110 countries globally and 26 US states on their viral hepatitis elimination programs. It is headquartered in Lafayette, Colorado.

Contact: Homie Razavi
  hrazavi@cdafound.org


Center for Disease Analysis Foundation Announces Receipt of an $8 Million Grant from Gilead Sciences to Relink Hepatitis B and C Patients to Care in the United States

TIN LIÊN QUAN

Cowlitz Tribal Foundation Celebrates 2022 Grant Recipients

The Cowlitz Tribal Foundation’s philanthropic efforts topped $8 million in 2022, with grants distributed to 110 nonprofits in Clark County and throughout...

Terracon Foundation Awards Over $90,000 in Grants

Grants and scholarships made to universities and organizations throughout U.S....

Seattle Humane to Address Lack of Affordable Veterinary

Bellevue, Washington, Feb. 09, 2023 (GLOBE NEWSWIRE) -- Nearly 50 million pets in the U.S. cannot access even the most basic veterinary care. Due to cost...

DentaQuest Opens Nominations for 2023 Health Equity Heroes

The awards recognize individuals and organizations working toward equitable access to oral care and optimal health outcomes...

THỦ THUẬT HAY

Hướng dẫn tải ứng dụng camera của Google Pixel cho máy Android khác

Google Pixel được giới công nghệ đánh giá khá cao chất lượng camera cũng như chế độ HDR+ trứ danh. Thì nay, các bạn đã có thể cài đặt ứng dụng...

Tìm hiểu về tính năng OneDrive Files On-Demand

OneDrive Files On-Demand là một tính năng mới thú vị và hữu ích trên Windows 10. Tính năng này hiện có sẵn trên Windows 10 Insider Build. Với người dùng chưa biết về tính năng này, OneDrive Files On-Demand tương tự như

Ứng dụng PC COVID là gì? Nó sẽ được sử dụng như thế nào trong thời gian sắp tới?

Ứng dụng PC COVID sắp ra mắt dự kiến sẽ thay thế và tích hợp các ứng dụng phòng chống COVID-19 hiện nay. App này đang được triển khai và chuẩn bị có mặt trên các kho ứng dụng.

Chế độ Dark Mode có tiết kiệm pin không?Cách dùng Dark Mode hiệu quả

Dark Mode hay giao diện tối là chế độ phổ biến trên các dòng điện thoại hiện nay. Hôm nay, mình sẽ trả lời cho câu hỏi Dark Mode có thật sự tiết kiệm hay không...

Delete và erase, wipe và shred khác nhau như thế nào?

Wiping, shredding, deleting, erasing có vẻ như đều mang những nét nghĩa giống nhau, nhưng về bản chất, các thao tác này mang những ý nghĩa hoàn toàn khác nhau.

ĐÁNH GIÁ NHANH

Đánh giá công dụng, lợi ích và mua cáp sạc nhanh iPhone 18W chính hãng giá cạnh tranh

Là người dùng iPhone chắc hẳn ai cũng cảm thấy khó chịu về hiệu năng pin của dòng sản phẩm Smart phone thương hiệu Apple này,dù các phiên bản về sau được cải thiện và nâng cấp đáng kể,nhưng có những trường hợp ta cần

Đánh giá HP ProBook 450 G4 - Thiết kế bền bỉ, hiệu năng ấn tượng với CPU Intel Core thế hệ thứ 7

Tiếp nối thành công của dòng laptop doanh nghiệp ProBook, HP tiếp tục ra mắt phiên bản ProBook G4 mới với nhiều cải tiến về thiết kế & hiệu năng mạnh

Đánh giá Xiaomi Redmi EarBuds 3 Pro: Tai nghe sở hữu chip Qualcomm xịn sò, thời lượng pin lên tới 30 tiếng, giá chưa đến 1 triệu đồng

Vừa qua, Xiaomi đã chính thức trình làng mẫu tai nghe không dây mới nhất có tên gọi Redmi EarBuds 3 Pro. Sản phẩm không chỉ sở hữu vẻ ngoài trẻ trung với nhiều tùy chọn màu cá tính, mà nó còn được trang bị nhiều tính